Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 51 to 100 of 132

TitleReference numberPublishedLast updated
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Integrated health and social care for people experiencing homelessnessNG214
Intramedullary distraction for lower limb lengtheningIPG718
Intramedullary distraction for upper limb lengtheningIPG722
Joint replacement (primary): hip, knee and shoulderQS206
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)TA774
Liposuction for chronic lipoedemaIPG721
Liposuction for chronic lymphoedemaIPG723
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
Lumella point-of-care test for assessing pre-eclampsia riskMIB287
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Mental wellbeing at workNG212
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Microwave ablation for primary or metastatic cancer in the lungIPG716
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754
Multiple sclerosis in adults: managementNG220
myCOPD for managing chronic obstructive pulmonary diseaseMTG68
Neonatal parenteral nutritionQS205
Nerve graft for corneal denervationIPG729
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Nivolumab with ipilimumab for untreated advanced renal cell carcinomaTA780
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)TA762
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resectionTA761
Otitis media (acute): antimicrobial prescribingNG91
Palforzia for treating peanut allergy in children and young peopleTA769
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuriaTA778
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapiesTA772
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancerTA801
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitisIPG720
Peristeen Plus transanal irrigation system for managing bowel dysfunctionMTG36
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndromeIPG724
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA776
Ponesimod for treating relapsing–remitting multiple sclerosisTA767
PredictSURE IBD and IBDX to guide treatment of Crohn's diseaseDG45
Preterm labour and birthNG25
Prontosan for treating acute and chronic woundsMTG67
Prostate cancerQS91
Prostate cancer: diagnosis and managementNG131
Reducing sexually transmitted infectionsNG221
Rehabilitation after traumatic injuryNG211
Romosozumab for treating severe osteoporosisTA791
SecurePort IV tissue adhesive for use with percutaneous cathetersMIB288
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careMTG65
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancerTA760

Results per page

  1. 10
  2. 25
  3. 50
  4. All